# OSENVELT
> **BLA761404** · Biologics License Application · Sponsor: CELLTRION INC · Approved 2025-02-28
## Drug
- **FDA Application Number:** BLA761404
- **Application type:** Biologics License Application
- **Brand name:** OSENVELT
- **Generic name:** DENOSUMAB-BMWO
- **Active ingredients:** DENOSUMAB-BMWO
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** CELLTRION INC
- **Manufacturer:** CELLTRION USA, Inc.
- **First approval:** 2025-02-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761404)
---
*AI Analytics · CC0 1.0*